AAAAAA

   
Results: 1-11 |
Results: 11
NEOPLASTIC MENINGITIS - A GUIDE TO DIAGNOSIS AND TREATMENT
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, NEOPLASTIC MENINGITIS - A GUIDE TO DIAGNOSIS AND TREATMENT, CNS drugs, 10(1), 1998, pp. 25-41
PRACTICAL GUIDELINES FOR THE TREATMENT OF MALIGNANT GLIOMAS
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, PRACTICAL GUIDELINES FOR THE TREATMENT OF MALIGNANT GLIOMAS, Western journal of medicine, 168(2), 1998, pp. 114-120
INTRAVENTRICULAR CHEMOTHERAPY - RESPONSE
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, INTRAVENTRICULAR CHEMOTHERAPY - RESPONSE, Journal of neurosurgery, 89(1), 1998, pp. 173-173
CHRONIC ORAL VP-16 FOR RECURRENT MEDULLOBLASTOMA
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, CHRONIC ORAL VP-16 FOR RECURRENT MEDULLOBLASTOMA, Pediatric neurology, 17(3), 1997, pp. 230-234
SALVAGE CHEMOTHERAPY WITH PACLITAXEL FOR RECURRENT OLIGODENDROGLIOMAS
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, SALVAGE CHEMOTHERAPY WITH PACLITAXEL FOR RECURRENT OLIGODENDROGLIOMAS, Journal of clinical oncology, 15(12), 1997, pp. 3427-3432
NON-AIDS-RELATED LYMPHOMATOUS MENINGITIS - COMBINED-MODALITY THERAPY
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, NON-AIDS-RELATED LYMPHOMATOUS MENINGITIS - COMBINED-MODALITY THERAPY, Neurology, 49(6), 1997, pp. 1728-1731
COMPLICATIONS ASSOCIATED WITH INTRAVENTRICULAR CHEMOTHERAPY IN PATIENTS WITH LEPTOMENINGEAL METASTASES
Authors: KORMANIK PA CHAMBERLAIN MC
Citation: Pa. Kormanik et Mc. Chamberlain, COMPLICATIONS ASSOCIATED WITH INTRAVENTRICULAR CHEMOTHERAPY IN PATIENTS WITH LEPTOMENINGEAL METASTASES, Neurology, 48(3), 1997, pp. 1013-1013
COMPLICATIONS ASSOCIATED WITH INTRAVENTRICULAR CHEMOTHERAPY IN PATIENTS WITH LEPTOMENINGEAL METASTASES
Authors: CHAMBERLAIN MC KORMANIK PA BARBA D
Citation: Mc. Chamberlain et al., COMPLICATIONS ASSOCIATED WITH INTRAVENTRICULAR CHEMOTHERAPY IN PATIENTS WITH LEPTOMENINGEAL METASTASES, Journal of neurosurgery, 87(5), 1997, pp. 694-699
PROGNOSTIC-SIGNIFICANCE OF COEXISTENT BULKY METASTATIC CENTRAL-NERVOUS-SYSTEM DISEASE IN PATIENTS WITH LEPTOMENINGEAL METASTASES
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, PROGNOSTIC-SIGNIFICANCE OF COEXISTENT BULKY METASTATIC CENTRAL-NERVOUS-SYSTEM DISEASE IN PATIENTS WITH LEPTOMENINGEAL METASTASES, Archives of neurology, 54(11), 1997, pp. 1364-1368
PROGNOSTIC-SIGNIFICANCE OF (111)INDIUM-DTPA CSF FLOW STUDIES IN LEPTOMENINGEAL METASTASES
Authors: CHAMBERLAIN MC KORMANIK PA
Citation: Mc. Chamberlain et Pa. Kormanik, PROGNOSTIC-SIGNIFICANCE OF (111)INDIUM-DTPA CSF FLOW STUDIES IN LEPTOMENINGEAL METASTASES, Neurology, 46(6), 1996, pp. 1674-1677
EXTENDED CSF CYTARABINE EXPOSURE FOLLOWING INTRATHECAL ADMINISTRATIONOF DTC-101
Authors: KIM S CHATELUT E KIM JC HOWELL SB CATES C KORMANIK PA CHAMBERLAIN MC
Citation: S. Kim et al., EXTENDED CSF CYTARABINE EXPOSURE FOLLOWING INTRATHECAL ADMINISTRATIONOF DTC-101, Journal of clinical oncology, 11(11), 1993, pp. 2186-2193
Risultati: 1-11 |